The psoriasis treatment landscape continues to expand in 2017 3 new drugs gained fda approval for the treatment of psoriatic arthritis psa and in march 2018 a new monoclonal antibody tildrakizumab ilumya was fda approved for plaque psoriasis. Current emerging treatments for psoriasis steven r feldman psoriasis clinical spectrum and classification enno christophers pathophysiology and new targets for drug development abhishek aphale andrew johnston johann gudjonsson current treatment options in psoriasis topical agents kristine b zitelli ali alikhan current treatment options phototherapy eric s lee . This chapter reviews the evidence for current and emerging therapies in all clinical domains of psa keywords psoriatic arthritis psoriasis tnf inhibition il12 23 inhibition il17 inhibition il23 inhibition jak inhibition pde4 inhibition this is a preview of subscription content log in to check access notes acknowledgments catherine loeffler manuscript preparation assistance disclosures . Current and emerging treatments for psoriatic arthritis chapter january 2018 with 25 reads how we measure reads a read is counted each time someone views a publication summary such as the . There are many therapeutic options available ranging from topical agents to phototherapy and systemic and biologic agents 12 this article discusses established therapies for psoriasis and their
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )